|
|
|
|
Psychiatric OSCE Performance of Students With and Without a Previous Core Psychiatry Clerkship
BMC Musculoskeletal Disorders, 03/22/10 Relevance Score: 66% International Journal of Eating Disorders, 02/23/10 Relevance Score: 66% Psychiatric Annals, 02/17/ Psychiatric OSCE Performance of Students With and Without a Previous Core Psychiatry Clerkship...
|
|
|
New Tool Launched Online To Help Prevent Musculoskeletal Disorders
A new downloadable tool is now available to help businesses and organisations reduce the likelihood of their employees suffering from musculoskeletal disorders (MSDs) of the upper limbs associated with repetitive tasks.MSDs are the most common occupational...
|
|
|
Osteochondral allograft reconstruction of segmental defect of humeral head after posterior dislocation of the shoulder
International Orthopaedics, 02/19/10 Relevance Score: 93% Journal of Rehabilitation Medicine, 03/17/10 Relevance Score: 92% Emergency Radiology, 03/01/10 Relevance Score: 91% HSS Journal (Musculoskeletal Journal of Hospital for Special Surg Osteochondral...
|
|
|
Unique Guideline Demonstrates A Multi-Specialty Outlook For Musculoskeletal Ultrasound
The AIUM is pleased to announce that 4 professional societies have collaborated with AIUM to endorse the recent AIUM Training Guidelines for the Performance of Musculoskeletal Ultrasound Examinations.The guidelines allow for a several practitioners,...
|
|
|
Endorsing AIUM Training Guidelines marks promise for the future of musculoskeletal ultrasound
A number of societies have endorsed this unique guideline, demonstrating a multi-specialty outlook for the technology The AIUM is pleased to announce that 4 professional societies have collaborated with AIUM to endorse the recent AIUM Training Guidelines for...
|
|
|
The GE Venue 40 series
Miniaturised ultrasound for fast POC settings GE Healthcare is presenting its new Venue ultrasound product line at Medica.The Venue 40, the first product launched, provides visualisation for needle guidance procedures and rapid diagnostics in real-time at...
|
|
|
Bone Biologics receives Notice of Allowance of patent claims that protects formation of cartilage by UCB-1
Bone Biologics, Inc.announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of...
|
|
|
AIUM Training Guidelines for Musculoskeletal Ultrasound Performance
The AIUM announced that 4 professional societies have collaborated with AIUM to endorse the recent AIUM Training Guidelines for the performance of musculoskeletal ultrasound examinations.The guidelines allow for a several practitioners, including physicians,...
|
|
|
Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound
The AIUM is pleased to announce that 4 professional societies have collaborated with AIUM to endorse the recent AIUM Training Guidelines for the Performance of Musculoskeletal Ultrasound Examinations.The guidelines allow for a several practitioners,...
|
|
|
LMBRU Installs Siemens Healthcare's MAGNETOM Verio
Leeds research unit installs wide bore system from Siemens Healthcare for high quality imaging and improved patient comfort Scientists at the Leeds Musculoskeletal Biomedical Research Unit (LMBRU), based at Chapel Allerton Hospital, have recently welcomed...
|
|
|
Hospital of Special Surgery Adds Musculoskeletal Radiology Fellowship Program
Radiologists who want to specialize in musculoskeletal imaging have a new fellowship option.Hospital of Special Surgery Adds Musculoskeletal Radiology Fellowship Program.
|
|
|
Management of inflammatory arthritis in older people
Paskins Z et al.Musculoskeletal symptoms are extremely common, with almost onethird of people aged 75 years and over having a significant musculoskeletal problem. Joint pain due to inflammatory arthritis is important to identify, as it is potentially...
|
|
|
Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation
Click the browser's refresh button to reload the requested page Click the browse Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation.
|
|
|
First Middle East Pain & Inflammation Academy held in Dubai
Two day initiative focused on sharing best practice, latest advances, challenges and solutions in the field of pain and management of chronic inflammatory disorders Over 180 of the most eminent regional pain and chronic inflammatory disorders management...
|
|
|
Musculoskeletal deformities secondary to neurotomy of the superior trunk of the brachial plexus in neonatal mice
The developmental course of musculoskeletal deformities in neonatal brachial plexus palsy (NBPP) has not been studied extensively.The goals of this study were to: (1) evaluate a new animal model of NBPP, (2) characterize the development of musculoskeletal...
|
|
|
Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of C
THOUSAND OAKS, Calif., March 11 /PRNewswire/ Bone Biologics, Inc.announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1).
|
|
|
Musculoskeletal Rehabilitation in the Person with Scleroderma
Which rehabilitation techniques help ease musculoskeletal impairments in patient Musculoskeletal Rehabilitation in the Person with Scleroderma.
|
|
|
Important Missing Links in the Treatment of Chronic Low Back Pain Patients
Revista de la Sociedad Espaola del Dolor, 02/09/10 Relevance Score: 95% Revista de la Sociedad Espaola del Dolor, 03/11/10 Relevance Score: 94% BMC Musculoskeletal Disorders, 02/11/10 Relevance Score: 94% Journal of Pain and Symptom Man Important Missing...
|
|
|
Management of displaced comminuted patellar fracture with titanium cable cerclage
The Journal of Bone and Joint Surgery (British Volume), 03/11/10 Relevance Score: 69% Postgraduate Medicine, 03/02/10 Relevance Score: 69% Paediatrics and Child Health, 02/17/10 Relevance Score: 69% The Journal of Musculoskeletal Medicine, Management of...
|
|
|
Topical NSAID Therapy for Musculoskeletal Pain
Haroutiunian S et al.Topical NSAIDs may vary significantly in their absorption kinetics and pharmacodynamic effects, based on NSAID molecule and the formulation chosen. Topical NSAID Therapy for Musculoskeletal Pain.
|
|
|
Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process
THOUSAND OAKS, Calif., March 11 /PRNewswire/ Bone Biologics, Inc.announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the methods of expressing, secreting, and purifying the NELL-1 sequence of...
|
|
|
Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of C
THOUSAND OAKS, Calif., March 11 /PRNewswire/ -- Bone Biologics, Inc.announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1).
|
|
|
Bone Biologics Announces a Major US Patent Issuance For Its Recombinant Protein Process For the Formation of Cartilage
Companies mentioned in this article: Bone Biologics, Inc.THOUSAND OAKS, Calif., March 11 /PRNewswire/ -- Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation...
|
|
|
Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation
THOUSAND OAKS, Calif., March 10 /PRNewswire/ -- Bone Biologics, Inc.announced today it had received another round of investment for preferred shares from the Musculoskeletal Transplant Foundation (MTF). MTF now owns 51% of Bone Biologics. As part...
|
|
|
Bone Biologics Announces Another Round of Equity and Debt Investment by Musculoskeletal Transplant Foundation and the Addition of Board Member, Mark S
THOUSAND OAKS, Calif., March 10 /PRNewswire/ -- Bone Biologics, Inc.announced today it had received another round of investment for preferred shares from the Musculoskeletal Transplant Foundation (MTF). MTF now owns 51% of Bone Biologics. As part...
|
